insilTox ApS: Financial statements 2024
CVR: 36996641
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
insilTox ApS (CVR 36996641) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 110,895 and a net result of DKK 3,861 compared with DKK -7,701 the year before. That is a decrease of 47% compared with the year before. Equity in the 2024 report amounted to DKK 43,496. The solvency ratio was 85.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 110,895
- Profit/Loss
- DKK 3,861
- Equity
- DKK 43,496
- Total Assets
- DKK 50,930
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 111K | 4K | 43K | 1 |
| 2023 | - | 209K | -8K | 40K | 1 |
| 2022 | - | 140K | 3K | 47K | 1 |
| 2021 | - | 78K | -28K | 45K | 1 |
| 2020 | - | 137K | 43K | 72K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
InsilTox ApS has published its annual report for 2023. Gross profit came to DKK 209,293, and the net result was DKK -7,701.
About insilTox ApS
insilTox ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2015. The company is registered under the industry Anden teknisk rådgivning. The management consists of Svava Osk Jonsdottir. The company is owned by insilTox Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 158,376 and a net result of DKK 3,502 compared with DKK 3,861 the year before. Equity in the 2025 report amounted to DKK 46,998.